Daratumumab in Primary Antiphospholipid Syndrome
Daratumumab in Primary Antiphospholipid Syndrome
Recruiting · NCT05671757 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Daratumumab in Primary Antiphospholipid Syndrome | antiphospholipid syndrome, autoimmune disease, immune system disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT05671757 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University | Durham | United States | 160 |
| Hospital for Special Surgery | New York | United States | 106 |
| Johns Hopkins University | Baltimore | United States | 60 |
| Mayo Clinic Rochester | Rochester | United States | 133 |
| Northwell Health | Great Neck | United States | 17 |
| NYU Langone | New York | United States | 34 |
| University of Michigan | Ann Arbor | United States | 538 |
| Weill Cornell | New York | United States | 5 |